Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

973 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers.
den Hollander MW, Westerink ND, Lubberts S, Bongaerts AH, Wolf RF, Altena R, Nuver J, Oosting SF, de Vries EG, Walenkamp AM, Meijer C, Gietema JA. den Hollander MW, et al. Among authors: de vries eg. Oncologist. 2016 Aug;21(8):995-1001. doi: 10.1634/theoncologist.2015-0451. Epub 2016 Jun 21. Oncologist. 2016. PMID: 27328932 Free PMC article.
The role of apoptosis-related genes in non-small-cell lung cancer.
Fokkema E, Groen HJ, Meijer C, Timens W, de Jong S, de Vries EG. Fokkema E, et al. Among authors: de vries eg, de jong s. Clin Lung Cancer. 2002 Nov;4(3):174-82. doi: 10.3816/clc.2002.n.025. Clin Lung Cancer. 2002. PMID: 14706167
The dilemma of the strive for apoptosis in oncology: mind the heart.
Perik PJ, de Vries EG, Gietema JA, van der Graaf WT, Sleijfer DT, Suurmeijer AJ, van Veldhuisen DJ. Perik PJ, et al. Among authors: de vries eg. Crit Rev Oncol Hematol. 2005 Feb;53(2):101-13. doi: 10.1016/j.critrevonc.2004.10.001. Crit Rev Oncol Hematol. 2005. PMID: 15661561 Review.
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer.
Hoekstra R, de Vos FY, Eskens FA, Gietema JA, van der Gaast A, Groen HJ, Knight RA, Carr RA, Humerickhouse RA, Verweij J, de Vries EG. Hoekstra R, et al. Among authors: de vries eg, de vos fy. J Clin Oncol. 2005 Aug 1;23(22):5188-97. doi: 10.1200/JCO.2005.05.013. J Clin Oncol. 2005. PMID: 16051960 Clinical Trial.
Phase I trial with BMS-275183, a novel oral taxane with promising antitumor activity.
Bröker LE, de Vos FY, van Groeningen CJ, Kuenen BC, Gall HE, Woo MH, Voi M, Gietema JA, de Vries EG, Giaccone G. Bröker LE, et al. Among authors: de vries eg, de vos fy. Clin Cancer Res. 2006 Mar 15;12(6):1760-7. doi: 10.1158/1078-0432.CCR-05-2093. Clin Cancer Res. 2006. PMID: 16551860 Free article. Clinical Trial.
973 results